Navigation Links
AccuVein Inks National Three-Year Group Purchasing Deal With Amerinet
Date:6/8/2009

Amerinet Offering AccuVein's AV300 Hand-Held Vein Illumination Device to Membership

COLD SPRING HARBOR, N.Y., June 8 /PRNewswire/ -- AccuVein LLC today announced a three year agreement with Amerinet Inc. to offer the AccuVein AV300, the world's first hand-held, non-contact vein illumination device to its members. The AccuVein AV300 projects a pattern of light on a patient's skin revealing vein position to help the healthcare professional locate veins for blood draw (venipuncture), IV starts and blood donation.

"Amerinet's network will help us introduce the AccuVein AV300 into health care facilities across the nation supporting our goal to provide all health professionals with a device that may reduce time and effort in establishing an IV line," said Stephen P. Conlon, President, AccuVein.

"The AccuVein AV300 embodies the types of tools we prefer to offer, with an eye to helping reduce healthcare costs and improving healthcare quality," said Randall (Randy) Walter, Executive Vice President, Contracting, Enterprise Solutions, Inquisit and Marketing, Amerinet Inc. Amerinet is a leading national healthcare group purchasing organization of over 30,000 members, including hospitals, physician offices, surgery centers, EMT/Emergency Medicine and Long Term Care sites.

About AccuVein

AccuVein applies advanced technologies to important healthcare challenges. Their innovative AV300 allows practitioners to see a map on the patient's skin of the position of veins, helping caregivers locate veins while they perform the most common invasive medical procedure -- venipuncture. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. With more than a dozen patents filed worldwide, AccuVein demonstrates an ongoing commitment to invest in improving patient care and patient satisfaction.

For more information on the AccuVein AV300, please visit www.AccuVein.com.

About Amerinet

As a leading group purchasing organization, Amerinet strategically partners with healthcare providers to reduce costs and improve quality.

Through its Total Spend Management solutions and operational performance improvement programs, tools and services, Amerinet assists members in their efforts to reduce costs, improve efficiencies and create new revenue streams. Supported by a team of clinical, data and supply chain experts, Amerinet offers a comprehensive portfolio of product and service contracts to address members' specific needs.

Based in St. Louis, Amerinet serves acute and alternate care site healthcare providers nationwide. To learn more, visit www.amerinet-gpo.com.


'/>"/>
SOURCE AccuVein
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Yongye Biotechnology International Receives License to Manufacture Products
2. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
3. Call for papers for Pira International's Global Crop Protection Summit 2009
4. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation
5. BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine
6. As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention
7. ViroPharma Incorporated Honored by the National Organization for Rare Disorders
8. Rodobo International, Inc. Reports Q2 and First Half of 2009
9. Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22
10. Professor Wing Wong Elected to the National Academy of Sciences
11. PRA International Participating in Pharmacoeconomics and Outcomes Research Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... maternal age to IVF success. , After comparing the results from the fresh ...
(Date:10/10/2017)... CALIF. (PRWEB) , ... October 10, 2017 , ... San ... part of its corporate rebranding initiative announced today. The bold new look is ... reach, as the company moves into a significant growth period. , It will also ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
Breaking Biology News(10 mins):